Bayer, Hua Medicine snag first-in-class nod in China for Roche castoff diabetes drug

China’s Hua Medicine has spent over a decade on one medicine—a diabetes candidate in-licensed from Roche. Now under a partnership with Bayer, the drug has snagged a global first-in-class nod in China.